Moreover, we asked if therapeutic application of LXA4, a well-characterized SPM with pro-resolving activity at least in mice, improves liver damage in Alox12/15−/− and Alox12/15+/+ mice subjected to an established animal model of alcoholic hepatitis (21). Here, ALOX12 is linked to alcoholic hepatitis.